Autopsy report · NCT04493333

Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors

“Low recruitment/enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Ran for about 2 years 1 month before it stopped.
• 8 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Arkansas

Sponsor type

University, hospital or other

Conditions

Vaginal Atrophy; Postmenopausal Symptoms; Breast Cancer Female; Long-term Survivors

Interventions

Vaginal Dehydroepiandrosterone; Vaginal Polycarbophil Moisturizer

Participants

8

Sites

1

Countries

United States

Trials that died the same way

• Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
  “Low subject recruitment and enrollment.” (88% match in meaning)
• Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes
  “insufficient recruitment/enrollment” (85% match in meaning)
• NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma
  “Low recruitment” (82% match in meaning)
• Study of Psychomotor Development and Attachment in Children Aged 6 to 30 Months With Oral Disorder
  “Recruitment too low” (81% match in meaning)
• Effect of Spinal Manipulation on Vulvar Pain
  “Lack of participants in available recruitment area” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.